The upper, middle and lower reaches of the medical imaging industry chain are respectively composed of parts suppliers, imaging equipment manufacturers and terminal application scenarios. As the "milestone" breakthrough process of leading foreign companies' products gradually slows down, the medical imaging equipment industry has entered the platform stage of mature technology, and companies are more focused on clinical needs and product performance optimization. The slowdown of this frontier leapfrog breakthrough process provides a valuable window period for Chinese companies to tackle technical problems.

In the past two years, domestic medical device manufacturers have carried out independent research and development and production in the fields of key core technologies and key components, and gradually broke through the "neck" problem of core technology and spare parts of products. Among them, many products have been selected into the list of "CT equipment with key core technologies and key spare parts in China's medical industry" and "MRI equipment with key core technologies and key spare parts in China's medical industry". The domestic medical imaging equipment industry chain is gradually maturing.

With the comprehensive acceleration of domestic substitution in the upstream supply chain of the imaging industry chain, and the continuous catch-up of domestic brand equipment performance, domestic medical device manufacturers have ushered in an important development stage, and the product structure has been upgraded from low-end to high-end or even ultra-high-end. Taking United Imaging Medical's high-end PET/CT equipment as an example, from the perspective of technical parameters and indicators, some performance parameters and indicators are already better than those of foreign competitors. At the same time, with the expansion of downstream applications driven by new medical infrastructure, domestic imaging equipment will usher in a golden age of domestic substitution.

In order to break the situation where foreign medical device companies occupy the domestic market, in recent years, many national departments have released signals to accelerate the localization of medical devices.

Since 2014, the China Medical Equipment Association has organized the selection of excellent domestic medical equipment products, gradually guided the improvement of the quality of domestic medical equipment, and promoted the branding and localization of medical equipment; in 2021, the newly revised "Medical Device Supervision and Management Regulations" was officially implemented to encourage the innovative development of medical devices, and through policies such as priority approval of innovative medical devices, it helped to significantly shorten the product launch cycle, rapidly increase the market share of domestic products, and accelerate the domestic substitution of medical device products...